Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Passive transfer of protection against Bacillus anthracis infection in a murine model.

Literature DB >> 11483266

Passive transfer of protection against Bacillus anthracis infection in a murine model.

R J Beedham¹, P C Turnbull, E D Williamson.

Abstract

Passive transfer of lymphocytes and sera from mice immunised using two different formulations containing recombinant protective antigen (rPA) have been used to further elucidate the mechanism of protection against Bacillus anthracis infection. The results demonstrated that an antibody response maybe important in protection against B. anthracis infection, under the conditions tested. The results provide further data for the development of an improved anthrax vaccine.

Entities: Disease Species

Mesh：

Substances：

Year: 2001 PMID： 11483266 DOI： 10.1016/s0264-410x(01)00197-9

Source DB: PubMed Journal: Vaccine ISSN： 0264-410X Impact factor: 3.641

Keyword Cloud
Cited

39 in total

1. Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax.

Authors: E D Williamson; I Hodgson; N J Walker; A W Topping; M G Duchars; J M Mott; J Estep; C Lebutt; H C Flick-Smith; H E Jones; H Li; C P Quinn
Journal: Infect Immun Date: 2005-09 Impact factor: 3.441

2. An anthrax lethal factor-neutralizing monoclonal antibody protects rats before and after challenge with anthrax toxin.

Authors: Nam-Kyu Lim; Jung-Hwan Kim; Mee Sook Oh; Sangyoon Lee; Se-Yeon Kim; Keun-Soo Kim; Hyun-Jung Kang; Hyo Jeong Hong; Kyung-Soo Inn
Journal: Infect Immun Date: 2005-10 Impact factor: 3.441

Review 3. Genetic medicine strategies to protect against bioterrorism.

Authors: Julie L Boyer; Ronald G Crystal
Journal: Trans Am Clin Climatol Assoc Date: 2006

4. Role of purine biosynthesis in Bacillus anthracis pathogenesis and virulence.

Authors: Amy Jenkins; Christopher Cote; Nancy Twenhafel; Tod Merkel; Joel Bozue; Susan Welkos
Journal: Infect Immun Date: 2010-11-01 Impact factor: 3.441

5. Evaluation of immunogenicity and efficacy of anthrax vaccine adsorbed for postexposure prophylaxis.

Authors: Boris Ionin; Robert J Hopkins; Brett Pleune; Gloria S Sivko; Frances M Reid; Kristin H Clement; Thomas L Rudge; Gregory V Stark; Alison Innes; Suha Sari; Tina Guina; Cris Howard; Jeffrey Smith; M Lisa Swoboda; Ekaterina Vert-Wong; Virginia Johnson; Gary S Nabors; Mario H Skiadopoulos
Journal: Clin Vaccine Immunol Date: 2013-05-08

6. A three-dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques.

Authors: Conrad P Quinn; Carol L Sabourin; Nancy A Niemuth; Han Li; Vera A Semenova; Thomas L Rudge; Heather J Mayfield; Jarad Schiffer; Robert S Mittler; Chris C Ibegbu; Jens Wrammert; Rafi Ahmed; April M Brys; Robert E Hunt; Denyse Levesque; James E Estep; Roy E Barnewall; David M Robinson; Brian D Plikaytis; Nina Marano
Journal: Clin Vaccine Immunol Date: 2012-08-29

7. Anthrax protective antigen delivered by Salmonella enterica serovar Typhi Ty21a protects mice from a lethal anthrax spore challenge.

Authors: Manuel Osorio; Yanping Wu; Sunil Singh; Tod J Merkel; Siba Bhattacharyya; Milan S Blake; Dennis J Kopecko
Journal: Infect Immun Date: 2009-01-29 Impact factor: 3.441